GSA Capital Partners’s Agilon Health AGL Stock Holding History

GSA Capital Partners’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.18M	Sell	29,703 -43,095	-59%	-$2.82M	0.2%	52
2026 Q1	$576K	Sell	72,798 -8,994	-11%	-$145K	0.04%	821
2025 Q4	$1.41M	Buy	+81,792	New	+$1.59M	0.12%	198
2025 Q3	–	Sell	-30,181	Closed	-$1.74M	–	1612
2025 Q2	$1.74M	Buy	+30,181	New	+$2.42M	0.12%	174
2024 Q4	–	Sell	-1,179	Closed	-$116K	–	1569
2024 Q3	$116K	Sell	1,179 -2,257	-66%	-$291K	0.01%	1478
2024 Q2	$562K	Sell	3,436 -1,033	-23%	-$147K	0.04%	885
2024 Q1	$681K	Buy	4,469 +3,360	+303%	+$559K	0.05%	694
2023 Q4	$348K	Buy	+1,109	New	+$401K	0.03%	1027
2023 Q2	–	Sell	-2,500	Closed	-$1.48M	–	1473
2023 Q1	$1.48M	Buy	2,500 +1,621	+184%	+$908K	0.15%	154
2022 Q4	$355K	Buy	+879	New	+$412K	0.04%	817

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

GSA Capital Partners's AGL Position: Q2 2026 in Review

GSA Capital Partners reduced its Agilon Health (AGL) stake by 59% in Q2 2026, selling an estimated $2.82M and leaving 29,703 shares worth $3.18M. The position accounts for 0.2% of the portfolio, ranked #52.

GSA Capital Partners first reported a position in AGL in Q4 2022 and has held it in 10 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

GSA Capital Partners held 29,703 shares of Agilon Health worth $3.18M as of Q2 2026.
GSA Capital Partners sold 43,095 Agilon Health shares in Q2 2026, an estimated $2.82M.
Agilon Health made up 0.2% of GSA Capital Partners's portfolio in Q2 2026, its #52 holding.
GSA Capital Partners first reported a position in Agilon Health in Q4 2022 and has held it in 10 quarters since.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.